The Regional Asian Clinical Trial Association (REACTA) was launched in 2013 by Taipei Medical University and clinical research centers of excellence in Japan, Korea, and Malaysia. Aiming to combine expertise in clinical trial, REACTA creates a platform to promote knowledge exchange and international collaboration in clinical trials across Asia.

REACTA 2024, taking place on 2 – 3 August in Taipei, will showcase key achievements of clinical trials across Taiwan, Japan, Korea, Malaysia and the wider Asia region, with focuses on the introduction of new technologies and application of AI to trial implementation in the digital era.